Infigratinib (BGJ398): an investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma

Gehan Botrus, Puneet Raman, Thomas Oliver, Tanios Bekaii-Saab

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Infigratinib (BGJ398): an investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences